ArticleOphthalmology science2026
The German National Cohort: Ophthalmic Assessment, Baseline Profile, and Potential for Artificial Intelligence-Based Eye Research.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe the ophthalmic examination protocol within the German National Cohort (NAKO)/NAKO Gesundheitsstudie, to report the baseline profile of participants undergoing ophthalmic assessment, and to illustrate the potential as a population-based resource for artificial intelligence (AI) research in eye health. Design: Baseline analysis of ophthalmic data within the nationwide, population-based multicenter prospective NAKO study. Participants: Forty-eight thousand four hundred and sixty adults in the ophthalmic level 2 module of 205 053 adults enrolled in NAKO, aged 19-74 years, with a mean age 48.9 ± 12.5 years, and 52.7% were male. Methods: All participants underwent standardized biomedical examinations and detailed questionnaire-based data collection, including nondilated color fundus imaging, visual acuity testing, and a brief ocular history. Ocular health was summarized using descriptive statistics. Fundus image quality and morphological features (e.g., cup-to-disc ratio and arteriolar-to-venular ratio) were assessed using open-source deep learning models. Standard deep learning architectures were trained on the fundus images to predict age, sex, and blood pressure. Main Outcome Measures: Percentage of fundus images graded as good quality; mean absolute error (MAE) for age and blood pressure prediction; accuracy for sex prediction. Results: The analysis includes 48 460 participants who completed the ophthalmic baseline examination of NAKO. Mean visual acuity (logarithm of the minimum angle of resolution) was 0.01 ± 0.20 (left eye, mean ± standard deviation) and 0.03 ± 0.21 (right eye). Self-reported ocular disease prevalence was 4.2% for cataract, 2.0% for glaucoma, and 0.9% for macular degeneration; 68.2% of fundus images were classified as gradable using 4 deep learning-based quality grading models. Morphological features showed systematic differences across age groups. Standard deep learning architectures showed comparative performance to the state-of-the-art for age, sex, and blood pressure prediction (2.96 MAE for age prediction, 0.84 accuracy for sex prediction, and 10.78 and 6.97 MAE for systolic and diastolic blood pressure prediction). Conclusions: The German National Cohort provides a large-scale, nationwide population-based resource with visual acuity measurements and systemic health indicators, as well as color fundus images in about 50 000 NAKO participants. These data lay the groundwork for studying eye health in the general adult population in Germany and can serve as a strong foundation for developing and validating AI tools in eye health research. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.